Background: Advances in genomics have led to calls for returning information about medically actionable genes (MAGs) to patients, research subjects, biobank participants, and through screening programs, the general adult population. Which MAGs are returned affects the harms and benefits of every genetic testing endeavor. Despite published recommendations of selection criteria for MAGs to return, scant data exist regarding how decision makers actually apply such criteria
As more research studies incorporate next-generation sequencing (including whole-genome or whole-exo...
Advances in genome sequencing and gene discovery have created opportunities to efficiently assess mo...
The American College of Medical Genetics and Genomics recently issued recommendations for reporting ...
Background: Advances in genomics have led to calls for returning information about medically actiona...
Purpose: Studies have begun exploring whether researchers should return incidental findings in genom...
Objective: The aim of this study was to identify the preferences for whole genome sequencing (WGS) t...
Advances in genomic technology allow us to seek information about hereditary conditions before indiv...
<b><i>Purpose:</i></b> Frameworks highlighting disease actionability and severity are evolving to ad...
Purpose: Comprehensive genomic analysis including exome and genome sequencing is increasingly being ...
Genetic screening can be hugely beneficial, yet its expansion poses clinical and ethical challenges ...
The debate about direct-to-consumer genetic testing has centred on whether consumers are the best ju...
As more research studies incorporate next-generation sequencing (including whole-genome or whole-exo...
Utilization of sequencing to screen the general population for preventable monogenic conditions is r...
Utilization of sequencing to screen the general population for preventable monogenic conditions is r...
One of the most controversial ethical issues in genomics research is the return of individual resear...
As more research studies incorporate next-generation sequencing (including whole-genome or whole-exo...
Advances in genome sequencing and gene discovery have created opportunities to efficiently assess mo...
The American College of Medical Genetics and Genomics recently issued recommendations for reporting ...
Background: Advances in genomics have led to calls for returning information about medically actiona...
Purpose: Studies have begun exploring whether researchers should return incidental findings in genom...
Objective: The aim of this study was to identify the preferences for whole genome sequencing (WGS) t...
Advances in genomic technology allow us to seek information about hereditary conditions before indiv...
<b><i>Purpose:</i></b> Frameworks highlighting disease actionability and severity are evolving to ad...
Purpose: Comprehensive genomic analysis including exome and genome sequencing is increasingly being ...
Genetic screening can be hugely beneficial, yet its expansion poses clinical and ethical challenges ...
The debate about direct-to-consumer genetic testing has centred on whether consumers are the best ju...
As more research studies incorporate next-generation sequencing (including whole-genome or whole-exo...
Utilization of sequencing to screen the general population for preventable monogenic conditions is r...
Utilization of sequencing to screen the general population for preventable monogenic conditions is r...
One of the most controversial ethical issues in genomics research is the return of individual resear...
As more research studies incorporate next-generation sequencing (including whole-genome or whole-exo...
Advances in genome sequencing and gene discovery have created opportunities to efficiently assess mo...
The American College of Medical Genetics and Genomics recently issued recommendations for reporting ...